ECSP16085143A - Metodo - Google Patents

Metodo

Info

Publication number
ECSP16085143A
ECSP16085143A ECIEPI201685143A ECPI201685143A ECSP16085143A EC SP16085143 A ECSP16085143 A EC SP16085143A EC IEPI201685143 A ECIEPI201685143 A EC IEPI201685143A EC PI201685143 A ECPI201685143 A EC PI201685143A EC SP16085143 A ECSP16085143 A EC SP16085143A
Authority
EC
Ecuador
Prior art keywords
alkyl
compound
formula
alkynyl
alkenyl
Prior art date
Application number
ECIEPI201685143A
Other languages
English (en)
Inventor
Stefano Biondi
Marco Forzatti
Giovanni Fogliato
Andrea Faini
Original Assignee
Allecra Therapeutics Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allecra Therapeutics Sas filed Critical Allecra Therapeutics Sas
Publication of ECSP16085143A publication Critical patent/ECSP16085143A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/87Compounds being unsubstituted in position 3 or with substituents other than only two methyl radicals attached in position 3, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1896Compounds having one or more Si-O-acyl linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Feed For Specific Animals (AREA)

Abstract

Un método de formación de un compuesto de fórmula (IIIa); en donde: R1 en cada ocurrencia se selecciona independientemente de H, halógeno, amino, alquilo de C1-5, alquenilo de C1-5 y alquinilo de C1-5; R2 en cada ocurrencia se selecciona independientemente de H, halógeno, amino, alquilo de C1-5, alquenilo de C1-5 y alquinilo de C1-5; R4 es alquilo de C1-5; y R6 es un fluoroalquilo de C1-5; y PG es un grupo protector; el método comprende el paso de hacer reaccionar un compuesto de fórmula (IIa) con un compuesto de fórmula (VIII).
ECIEPI201685143A 2014-05-15 2016-10-29 Metodo ECSP16085143A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1408649.0A GB201408649D0 (en) 2014-05-15 2014-05-15 Method

Publications (1)

Publication Number Publication Date
ECSP16085143A true ECSP16085143A (es) 2017-05-31

Family

ID=51134924

Family Applications (1)

Application Number Title Priority Date Filing Date
ECIEPI201685143A ECSP16085143A (es) 2014-05-15 2016-10-29 Metodo

Country Status (29)

Country Link
US (1) US9963465B2 (es)
EP (3) EP3231806B1 (es)
JP (1) JP6613303B2 (es)
KR (1) KR102329186B1 (es)
CN (1) CN106459086B (es)
AU (1) AU2015261416B2 (es)
BR (1) BR112016026074B1 (es)
CA (1) CA2945900C (es)
CL (2) CL2016002880A1 (es)
CR (1) CR20160580A (es)
CY (2) CY1120957T1 (es)
DK (2) DK3143028T3 (es)
EA (2) EA201991629A3 (es)
EC (1) ECSP16085143A (es)
ES (2) ES2725675T3 (es)
GB (1) GB201408649D0 (es)
HR (2) HRP20182065T1 (es)
HU (1) HUE044511T2 (es)
IL (1) IL248834B (es)
LT (2) LT3231806T (es)
MX (1) MX2016014644A (es)
PE (1) PE20161433A1 (es)
PL (2) PL3143028T3 (es)
PT (2) PT3231806T (es)
RS (2) RS58430B1 (es)
SG (1) SG11201609494YA (es)
SI (2) SI3143028T1 (es)
TR (1) TR201906867T4 (es)
WO (1) WO2015173378A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201319776D0 (en) * 2013-11-08 2013-12-25 Allecra Therapeutics Sas Compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1319776A (en) 1969-07-15 1973-06-06 Yorkshire Chemicals Ltd Basic dyes
SI2046802T1 (sl) * 2006-07-12 2014-03-31 Allecra Therapeutics Gmbh C/O Loeba Treuhand Gmbh 2-substituirani metil penamski derivati
KR101933084B1 (ko) 2010-11-25 2018-12-28 알레크라 테라퓨틱스 게엠베하 화합물 및 그의 용도
KR20120067257A (ko) * 2010-12-15 2012-06-25 서강대학교산학협력단 3-메틸-1,4-치환된 1,2,3-트라이아졸륨 기반의 이온성 액체 및 그의 제조방법과 응용

Also Published As

Publication number Publication date
HRP20190830T1 (hr) 2019-06-28
CA2945900A1 (en) 2015-11-19
SG11201609494YA (en) 2016-12-29
RS58748B1 (sr) 2019-06-28
CA2945900C (en) 2023-01-24
RS58430B1 (sr) 2019-04-30
ES2699644T3 (es) 2019-02-12
CN106459086B (zh) 2018-11-13
US9963465B2 (en) 2018-05-08
HRP20182065T1 (hr) 2019-02-08
EA201991629A2 (ru) 2019-12-30
LT3143028T (lt) 2018-12-27
WO2015173378A3 (en) 2016-01-14
TR201906867T4 (tr) 2019-05-21
IL248834A0 (en) 2017-01-31
EP3143028B1 (en) 2018-09-26
EP3441395A1 (en) 2019-02-13
CR20160580A (es) 2017-05-09
CL2016002880A1 (es) 2017-06-16
BR112016026074A8 (pt) 2021-03-30
JP2017515907A (ja) 2017-06-15
EA201991629A3 (ru) 2020-02-28
DK3231806T3 (da) 2019-05-20
KR102329186B1 (ko) 2021-11-22
DK3143028T3 (da) 2019-01-02
BR112016026074B1 (pt) 2023-01-03
IL248834B (en) 2019-05-30
MX2016014644A (es) 2017-02-23
JP6613303B2 (ja) 2019-11-27
LT3231806T (lt) 2019-05-27
PT3143028T (pt) 2018-12-17
ES2725675T3 (es) 2019-09-26
EP3231806A1 (en) 2017-10-18
PL3231806T3 (pl) 2019-08-30
CN106459086A (zh) 2017-02-22
HUE044511T2 (hu) 2019-10-28
AU2015261416B2 (en) 2019-07-11
PT3231806T (pt) 2019-05-30
KR20170002466A (ko) 2017-01-06
US20170101421A1 (en) 2017-04-13
CL2018001961A1 (es) 2018-08-31
WO2015173378A2 (en) 2015-11-19
NZ725121A (en) 2023-09-29
PE20161433A1 (es) 2017-01-18
SI3143028T1 (sl) 2019-01-31
EA033494B1 (ru) 2019-10-31
GB201408649D0 (en) 2014-07-02
EA201692306A1 (ru) 2017-05-31
EP3231806B1 (en) 2019-02-13
EP3143028A2 (en) 2017-03-22
PL3143028T3 (pl) 2019-04-30
SI3231806T1 (sl) 2019-06-28
CY1121756T1 (el) 2020-07-31
AU2015261416A1 (en) 2016-11-10
CY1120957T1 (el) 2019-12-11

Similar Documents

Publication Publication Date Title
CL2018000157S1 (es) Protector de borde para implemento de máquina excavadora
CO2017007355A2 (es) Compuestos derivados de pirazincarbozamida y de pirazincarboxilato para el tratamiento de la infección por el virus de hepatitis b
BR112018006034A2 (pt) compostos bicíclicos como inibidores de atx
BR112017021803A2 (pt) derivados bicíclicos de quinazolinona
CO2017012594A2 (es) Moduladores de receptor nuclear
CR20140306A (es) Fluormetil -5,6-dihidro-4h-[1,3] oxazinas
EA201991241A1 (ru) Способ получения метоксиметилпиридин дикарбоксилата
BR112018073100A2 (pt) material luminescente
CY1120763T1 (el) Νεες ενωσεις σουλφονυλαμινοβενζαμιδιου
MX2018003047A (es) Metodo para producir sales de biguanida y s-triazinas.
EA202190475A1 (ru) Мини-gde для лечения гликогеноза iii типа
EA201990238A1 (ru) ФОСФОРСОДЕРЖАЩИЕ ПРОЛЕКАРСТВА СТИМУЛЯТОРОВ sGC
BR112019007256A2 (pt) composições cosméticas
EA201891808A1 (ru) Трис-амидные соединения и композиции, содержащие их
MX2020003921A (es) Proceso para producir compuestos de tipo piridazinona herbicidas.
MA50537A (fr) Composés deutérés utilisés comme immunomodulateurs
BR112017005645A2 (pt) método de preparar cinamaldeído
CO2017003830A2 (es) Compuestos de piridina
EA201892449A1 (ru) Конденсированные гетероциклические соединения
ECSP16085143A (es) Metodo
AR101951A1 (es) Síntesis de ent-progesterona e intermediarios de la misma
CY1124594T1 (el) Καινοφανης πολυμορφικη μορφη της υδροχλωρικης ν-[2-(6-φθορο-lη-ινδολ-3-υλ)αιθυλ]-3-(2,2,3,3-τετραφθοροπροποξυ)βενζυλαμινης για την αγωγη της αλτσχαϊμεp
MX2020003922A (es) Proceso para producir compuestos de piridazinona herbicida.
EA201892406A1 (ru) Способ получения гербицидных пиридинилимидазолоновых соединений
UA107885U (uk) Застосування вінборону для профілактики гастропатії, індукованої ібупрофеном